Summary & Overview
HCPCS E0767: Intrabuccal Amplitude-Modulated RF Electromagnetic Cancer Therapy
HCPCS Level II code E0767 represents the intrabuccal, systemic delivery of an amplitude-modulated radiofrequency electromagnetic field device for cancer treatment, inclusive of all accessories. This code identifies a device-based oncologic therapy modality that targets systemic effects through intrabuccal application, and its presence in the HCPCS Level II code set signals payer recognition for billing and coverage assessment at a national level.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for device-based electromagnetic field oncology therapy, common billing considerations, and the types of benchmarks and policy updates typically relevant to HCPCS Level II device codes. The publication outlines how payers categorize the service, typical sites of service where it is furnished, and the implications for claim submission and coding workflows.
The content provides national-level context rather than state-specific guidance and highlights what to expect in payer policy language, documentation needs, and areas where coverage determinations and reimbursement policies often vary. Data not available in the input will be identified as such in the detailed sections.
Billing Code Overview
HCPCS Level II code E0767 describes intrabuccal, systemic delivery of an amplitude-modulated radiofrequency electromagnetic field device for cancer treatment, includes all accessories. The service involves delivering amplitude-modulated radiofrequency electromagnetic fields via an intrabuccal applicator to provide systemic therapeutic effects for oncology patients.
Service type: Device-based cancer therapy, electromagnetic field delivery
Typical site of service: Outpatient clinic or hospital outpatient department where device-based oncology therapies are administered
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a diagnosed head and neck or oral cavity malignancy receiving adjunctive local cancer therapy. The patient presents to an outpatient oncology or radiation oncology clinic for treatment with an intrabuccal amplitude‑modulated radiofrequency electromagnetic field device (E0767). The clinical workflow: history and recent imaging review by the oncology team; verification of indication and informed consent; oral exam and stabilization (dental clearance if needed prior to course); device setup and fit of intraoral applicator; delivery of prescribed intrabuccal radiofrequency electromagnetic field treatment session(s) with continuous monitoring for discomfort or adverse effects; documentation of treatment parameters, session duration, and any immediate reactions. Sessions may occur repeatedly over days to weeks per the treating oncologist’s plan. Typical sites of service are outpatient hospital clinic, physician office-based oncology practice, or ambulatory infusion/treatment center equipped for device use. Ancillary staff include radiation therapists or trained oncology nurses and supervising medical oncologist or radiation oncologist. Billing uses HCPCS Level II code E0767 to represent the device and its delivery, inclusive of accessories.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |